Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder
Small leucine-rich proteoglycans are components of extracellular matrix that regulates neoplastic transformation. Among small leucine rich proteoglycans, Decorin, Biglycan and Lumican are most commonly implicated markers, and their expression is well studied in various malignancies. In this novel st...
Saved in:
| Main Authors: | Sandeep Appunni, Vivek Anand, Madhuram Khandelwal, Amlesh Seth, Sandeep Mathur, Alpana Sharma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-04-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317699112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pivotal roles of biglycan and decorin in regulating bone mass, water retention, and bone toughness
by: Rui Hua, et al.
Published: (2025-01-01) -
Serum decorin and biglycan levels as predictive biomarkers for lung fibrosis severity and mortality risk in COVID-19 patients
by: Shaaf Ahmad, et al.
Published: (2025-01-01) -
The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice
by: Casey L. Egan, et al.
Published: (2025-07-01) -
Lumican as a potential biomarker for diabetic nephropathy
by: Yuejia Tao, et al.
Published: (2025-12-01) -
Knockdown of decorin in human bone marrow mesenchymal stem cells suppresses proteoglycan layer formation and establishes a pro-inflammatory environment on titanium oxide surfaces
by: Hisanobu Kamio, et al.
Published: (2025-01-01)